Importer of Controlled Substances Application: United States Pharmacopeial Convention, 43603 [2020-15465]

Download as PDF 43603 Federal Register / Vol. 85, No. 138 / Friday, July 17, 2020 / Notices INTERNATIONAL TRADE COMMISSION [Investigation Nos. 701–TA–626 and 731– TA–1452 (Final)] Certain Collated Steel Staples From China Determinations On the basis of the record 1 developed in the subject investigations, the United States International Trade Commission (‘‘Commission’’) determines, pursuant to the Tariff Act of 1930 (‘‘the Act’’), that an industry in the United States is materially injured by reason of imports of certain collated steel staples from China, provided for in subheading 8305.20.0000 of the Harmonized Tariff Schedule of the United States, that have been found by the U.S. Department of Commerce (‘‘Commerce’’) to be sold in the United States at less than fair value (‘‘LTFV’’), and to be subsidized by the government of China.2 Background khammond on DSKJM1Z7X2PROD with NOTICES The Commission instituted these investigations effective June 6, 2019, following receipt of petitions filed with the Commission and Commerce by Kyocera Senco Industrial Tools, Inc. (‘‘Senco’’), Cincinnati, Ohio. The final phase of the investigations was scheduled by the Commission following notification of preliminary determinations by Commerce that imports of certain collated steel staples from China were subsidized within the meaning of section 703(b) of the Act (19 U.S.C. 1671b(b)) and sold at LTFV within the meaning of 733(b) of the Act (19 U.S.C. 1673b(b)). Notice of the scheduling of the final phase of the Commission’s investigations and of a public hearing to be held in connection therewith was given by posting copies of the notice in the Office of the Secretary, U.S. International Trade Commission, Washington, DC, and by publishing the notice in the Federal Register on January 21, 2020 (85 FR 3417). In light of the restrictions on access to the Commission building due to the COVID–19 pandemic, and in accordance with 19 U.S.C. 1677c(a)(1), the Commission conducted its hearing via video conference on May 27, 2020; all persons who requested the 1 The record is defined in sec. 207.2(f) of the Commission’s Rules of Practice and Procedure (19 CFR 207.2(f)). 2 The Commission also finds that imports subject to Commerce’s affirmative critical circumstances determination are not likely to undermine seriously the remedial effect of the countervailing and antidumping duty orders on certain collated steel staples from China. VerDate Sep<11>2014 18:12 Jul 16, 2020 Jkt 250001 opportunity were permitted to participate. The Commission made these determinations pursuant to sections 705(b) and 735(b) of the Act (19 U.S.C. 1671d(b) and 19 U.S.C. 1673d(b)). It completed and filed its determinations in these investigations on July 13, 2020. The views of the Commission are contained in USITC Publication 5085 (July 2020), entitled Certain Collated Steel Staples from China: Investigation Nos. 701–TA–626 and 731–TA–1452 (Final). By order of the Commission. Issued: July 13, 2020. Lisa Barton, Secretary to the Commission. following basic class(es) of a controlled substance: Controlled substance Methcathinone .......................... Drug code Schedule 1237 I The company plans to import the listed controlled substance for distribution of analytical reference standards to its customers for analytical testing of raw materials. No other activities for this drug code are authorized for this registration. William T. McDermott, Assistant Administrator. [FR Doc. 2020–15465 Filed 7–16–20; 8:45 am] BILLING CODE P [FR Doc. 2020–15457 Filed 7–16–20; 8:45 am] BILLING CODE 7020–02–P DEPARTMENT OF JUSTICE DEPARTMENT OF JUSTICE Drug Enforcement Administration Drug Enforcement Administration [Docket No. DEA–669] [Docket No. DEA–682] Importer of Controlled Substances Application: Cambrex Charles City Importer of Controlled Substances Application: United States Pharmacopeial Convention ACTION: Notice of application. PO 00000 Frm 00072 Fmt 4703 Sfmt 4703 Notice of application. Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before August 17, 2020. Such persons may also file a written request for a hearing on the application on or before August 17, 2020. DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before August 17, 2020. Such persons may also file a written request for a hearing on the application on or before August 17, 2020. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All request for a hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this is notice that on June 17, 2020, United States Pharmacopeial Convention, 7135 English Muffin Way, Frederick, Maryland 21704, applied to be registered as an importer of the DATES: ACTION: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All request for a hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. ADDRESSES: In accordance with 21 CFR 1301.34(a), this is notice that on May 6, 2020, Cambrex Charles City, 1205 11th Street, Charles City, Iowa 50616, applied to be registered as an importer of the following basic class(es) of controlled substances: SUPPLEMENTARY INFORMATION: E:\FR\FM\17JYN1.SGM 17JYN1

Agencies

[Federal Register Volume 85, Number 138 (Friday, July 17, 2020)]
[Notices]
[Page 43603]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-15465]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-682]


Importer of Controlled Substances Application: United States 
Pharmacopeial Convention

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may file written comments on or objections to 
the issuance of the proposed registration on or before August 17, 2020. 
Such persons may also file a written request for a hearing on the 
application on or before August 17, 2020.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a 
hearing must be sent to: Drug Enforcement Administration, Attn: 
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All 
request for a hearing should also be sent to: (1) Drug Enforcement 
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, 
Springfield, Virginia 22152; and (2) Drug Enforcement Administration, 
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, 
Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this 
is notice that on June 17, 2020, United States Pharmacopeial 
Convention, 7135 English Muffin Way, Frederick, Maryland 21704, applied 
to be registered as an importer of the following basic class(es) of a 
controlled substance:

------------------------------------------------------------------------
                                           Drug
          Controlled substance             code          Schedule
------------------------------------------------------------------------
Methcathinone...........................    1237  I
------------------------------------------------------------------------

    The company plans to import the listed controlled substance for 
distribution of analytical reference standards to its customers for 
analytical testing of raw materials. No other activities for this drug 
code are authorized for this registration.

William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-15465 Filed 7-16-20; 8:45 am]
BILLING CODE P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.